Improving cervical cancer screening and treatment for HIV positive women in Kenya
Official title: Enhanced Cervical Cancer Screening Adoption and Treatment Linkage for HIV positive Women in Kenya (eCASCADE-Kenya)
Funded at Emory University · NIH-10931599 · Data updated 2026-11-12
This study is working to help HIV positive women in Kenya get better access to cervical cancer screenings and treatments, so they can catch any issues early and stay healthier.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | September 19, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $206,952 |
| NIH project number | 5U54CA284036-02 |
| Project ID | NIH-10931599 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are HIV positive women living in Kenya who are at risk for cervical cancer.
✕Less likely to help
Patients who are not HIV positive or those who do not reside in Kenya may not benefit from this research.
What this research studies
This research aims to enhance the adoption of cervical cancer screening and improve the linkage to treatment specifically for HIV positive women in Kenya. By addressing the significant gaps in healthcare access and implementation of cancer control measures, the project will utilize a collaborative approach involving community, clinical, and government stakeholders. The research will focus on developing effective strategies to ensure that women receive timely screenings and necessary treatments, ultimately reducing late-stage cancer presentations and improving health outcomes.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and treatment of cervical cancer in HIV positive women, significantly improving their health outcomes.
How similar studies have gone: Previous research has shown success in improving cancer screening and treatment linkages in similar populations, indicating that this approach has potential for impactful outcomes.
Where this research is happening
-
Emory University
Atlanta, United States Active
Researchers
- Principal investigator: Kosgei, Rose Jepchumba — Emory University
- Study coordinator: Kosgei, Rose Jepchumba
Related research
Other NIH-funded projects on the same topics.
-
mSaada: a mobile tool to boost cervical cancer screening in western Kenya
A mobile app helps community health volunteers manage cervical cancer screening tasks and follow-up for women in low-resource areas.
-
HPV self-collection in HIV care to screen for cervical cancer in Ethiopia
A patient-centered program tests a simple HPV self-collection approach within HIV clinics in Ethiopia to help detect cervical cancer earlier.
-
HOPE-inG: Increasing cervical cancer screening for women with HIV in Ghana
A study tests a home-based HPV self-sampling approach plus a tailored communication plan to help women living with HIV in Ghana get screened more often for cervical cancer.
-
CODA-based cervical cancer screening for LMICs using CRISPR and fluorescence
A low-resource, rapid test called CODA uses CRISPR and light signals to detect cervical cancer markers in women in sub-Saharan Africa to improve screening.
-
CODA-based cervical cancer screening in low-resource settings
A new, quick, low-cost test using CRISPR and fluorescence readouts to help screen for cervical cancer in women in sub-Saharan Africa.
-
CATSystem: a digital tool to boost cervical cancer screening and follow-up in Kenya
A digital tracking system helps doctors and patients in Kenya improve cervical cancer screening, treatment referrals, and follow-up, especially for women living with HIV.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.